4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine - CAS 946409-19-4
Category:
Main Product
Product Name:
4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine
Catalog Number:
946409-19-4
Synonyms:
4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)BENZYLAMINE; 4-(5-methyl-1,3,4- oxadiazol -2-yl)-benzenemethanamine
CAS Number:
946409-19-4
Molecular Weight:
189.21
Molecular Formula:
C10H11N3O
COA:
Inquire
MSDS:
Inquire
Chemical Structure
CAS 946409-19-4 4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzylamine

Reference Reading


1.Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
Saijo T1, Maeda J, Okauchi T, Maeda J, Morio Y, Kuwahara Y, Suzuki M, Goto N, Suzuki K, Higuchi M, Suhara T. Int J Neuropsychopharmacol. 2009 Sep;12(8):1021-32. doi: 10.1017/S1461145709000042. Epub 2009 Feb 23.
Visualization of neurotransmission components in living small animals using positron emission tomography (PET) has the potential of contributing to the preclinical development of neuroactive drugs, although it is yet to be examined whether quantitative animal PET data on candidate compounds can be extrapolated to humans. Here, we investigated the comparability of the occupancies of serotonin transporter (5-HTT) by therapeutic agents in rat PET studies with our predetermined data from ex- vivo animal experiments and clinical PET scans. Rats were treated with varying doses of fluvoxamine and a newly developed compound, (2S)-1-[4-(3,4-dichlorophenyl) piperidin-1-yl]-3-[2-(5-methyl-1,3,4-oxadiazol-2-yl)benzo[b]furan-4-yloxy]propan-2-ol monohydrochloride (Wf-516), and underwent PET scans with [11C]3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)-benzonitrile ([11C]DASB), a selective radioligand for in-vivo quantification of 5-HTT. PET images indicated a reduction of [11C]DASB binding to 5-HTT as a function of the doses and/or plasma concentrations of fluvoxamine and Wf-516.